Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a.

CONCLUSION: IFN treatment results in HBsAg loss and seroconversion in a considerable proportion of inactive HBsAg carriers with low HBsAg concentrations. PMID: 27239256 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/27239256?dopt=Abstract

Source: World Journal of Hepatology - June 1, 2016 Category: Gastroenterology Tags: World J Hepatol Source Type: research

More News: Gastroenterology | Hepatitis | Hepatitis B | Pegasys | Study